Quantitative profiling of PrPSc peptides by high-performance liquid chromatography mass spectrometry to investigate the diversity of prions

Abstract

Prions are proteins that can exist in two (or more) folding states, a normal or cellular form and a series of infectious or prion forms, which are prone to aggregate. The prion form can induce conversion of the cellular form and so transmit phenotypic effects of this structural rearrangement within and between cells and organisms. The conversion of PrPC, the mammalian prion glycoprotein, to its prion form, PrPSc, in the brain is a precursor to progressive neurological degeneration, and the various folded forms of PrPSc (defined by the size and glycosylation of protease-resistant core peptides of the PrP aggregates, PrPres) are characteristic of a particular neurodegenerative phenotype or prion disease. Here, quantitative multiplex mass spectrometry was used for N-terminal amino acid profiling (N-TAAP) of PrPres from sheep affected by scrapie, the prion disease of small ruminants, to rapidly assess the diversity of prions within particular flocks. In 29 cases, PrPres concentrations varied from below the limit of detection (350fmol/g) to 15pmol/g wet brain. Although most had a single N-TAAP profile, two novel variants were identified: one common to the ARH/ARQ animals in this study and one in an animal of the wild-type sheep PrP genotype (ARQ/ARQ).